Latest

Latest therapeutics News | Page 2

  • Latest therapeutics news stories and updates. What is happening today? All recent therapeutics news and developments. Live coverage and timeline of therapeutics. All you need to know about therapeutics.
Second WHO global technical consultation on public health and social measures during health emergencies, November 2023
ISU researcher wins innovation challenge to seek RNA drug targets
Strengthening Fiscal Responsibility Rules
Discovery of drug candidate to potentially tackle ER-positive breast cancer
World-first breakthrough in malaria treatment
La Trobe University and AdAlta collaboration delivers world-first breakthrough in malaria treatment
Genetic study aims to unlock new osteoporosis treatments
Hudson Institute welcomes inflammation specialist as new Centre Head
WHO’s Science Council issues report on mRNA vaccine technology
Prescient announces the results of PTX-100 Phase 1b study in T-cell lymphoma patients
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
Cynata Therapeutics secures approval for Phase 2 trial in Turkey
Microba Life Sciences announces results of successful Phase IBD trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune
Microba completes stage one screening for its autoimmune disease program
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
HKUST Scientists Unveil Promising Target for Alzheimer’s Disease Treatment
Opioid and psychotropic dispensing’s on the decline among Australians living with cystic fibrosis
Cracking the code: researchers unravel how mutant protein drives cancer growth
Oral delivery possibility for silica-based C’Dots
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Island Pharmaceuticals doses first cohort in ISLA-101 Single Ascending Dose study
The Cell and Gene Catalyst call for change in submission to scope of practice review
Alterity Therapeutics raises $4.8 million in new placement
ASX Hopeful Aegros Appoints Ex-MP As Advisory Committee Chair
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
Funding supports research speciality in WA
Antimicrobial Resistance: Silent Pandemic
Alterity Therapeutics announces presentation of new data for ATH434
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Australian-invented drug technology used for treatment of anxiety disorders significantly reduces stress hormone response: Phase 2a clinical trial results
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Professor Dion Stub announced as Heart Foundations new Chair of its Victorian Advisory Board
WHO updates guidelines on treatments for COVID-19
Boosting beta cells to treat Type 2 diabetes
Australia, US scientists team up on African swine fever vaccine
Jessica’s story, ovarian cancer at young age
New centre to develop treatments for aggressive cancers
Opthea announces leadership transition with the appointment of US-based executives
AusBioInvest 2023 connects innovators with investment
Public support needed to advance treatment in deadly brain cancers
AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech
WA’s innovative healthcare to be showcased on open day
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
AusBioInvest 2023 programme launched
‘We could see it happening before our eyes’: research shows how cancer cells resist chemotherapy
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial

© 2024 - The National Tribune Australia